Investing in hedge funds macro hedge funds gained 3

Macro hedge funds gained 3.8% last month, boosted by positions on short-duration U.S. Treasuries and currency trades against weaker EUR/USD moves. This data supports the thesis that investing in hedge funds with global macro exposure can hedge equity drawdowns amid geopolitical uncertainty. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. The variety in hedge fund bets echoes global uncertainty about where growth and risk really lie. Standout gains from funds like Bridgewater show there’s still room for diverse approaches, while the steady hand of systematic managers beams through ongoing changes. All told, hedge fund positioning now captures a world where inflation , shifting policies, and tech mega-caps continue to set an unpredictable pace for global investors. February saw hedge fund interest in biotech surge as FDA approvals triggered sharp price moves. Funds with sector-specific expertise averaged 8% monthly returns, highlighting the potential of investing in hedge funds positioned for healthcare innovation themes.